Mouse
Showing 1 - 25 of 2,758
Dietary Fiber, Gastrointestinal Microbiome, Healthy Volunteers Trial in Esch-sur-Alzette, Strassen (High Fiber Diet
Completed
- Dietary Fiber
- +2 more
- High Fiber Diet Intervention
- Low Fiber Diet Intervention
-
Esch-sur-Alzette, Luxembourg
- +1 more
Dec 6, 2022
Healthy Volunteers, Frail Volunteers Trial in Clermont-Ferrand (Stool collection)
Completed
- Healthy Volunteers
- Frail Volunteers
- Stool collection
-
Clermont-Ferrand, FranceCHU
Oct 5, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Tocilizumab
- Venetoclax
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jan 24, 2023
Root Caries, NaF, SDF Trial in Bern (Group A, Group B, Group C)
Not yet recruiting
- Root Caries
- +3 more
- Group A
- +3 more
-
Bern, SwitzerlandZahnmedizinklinik University of Bern, Department of Restorative,
Mar 14, 2023
Recurrent Brain Tumor Trial in Houston (biological, other, radiation)
Active, not recruiting
- Recurrent Brain Neoplasm
- Bevacizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,
Active, not recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Extracorporeal Photopheresis
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,
Recruiting
- Mycosis Fungoides
- +2 more
- Extracorporeal Photopheresis
- +2 more
-
Atlanta, GeorgiaEmory University Hospital
Jun 15, 2022
Carpal Tunnel Syndrome, Median Nerve Injury Trial in Los Angeles, Columbus (Cooling, Heating, Exercising)
Enrolling by invitation
- Carpal Tunnel Syndrome
- Median Nerve Injury
- Cooling
- +5 more
-
Los Angeles, California
- +1 more
May 12, 2022
Spine Posture and Mobility With Upper Extremity Functions in
Completed
- Parkinson
- +3 more
- Spinal Mouse (IDIAG M360 )
- Nine Hole Peg Test
-
Ankara, TurkeySağlık Bilimleri Üniversitesi
Jul 7, 2022
A Comparison of in People With and Without Non-Specific Low Back
Completed
- Low Back Pain
- Functional Movement Screen, Spinal Mouse, Core Endurance, Funcitonal Capacity
-
Istanbul, Beylikdüzü, TurkeyBeykent University
Jul 20, 2022
Trunk Position Sense and Spinal Posture With Balance in
Completed
- Parkinson Disease
- +4 more
- Spinal Mouse and Digital Inclinometer
-
Ankara, TurkeySağlık Bilimleri Üniversitesi
Jul 7, 2022
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Completed
- Platinum-Resistant Fallopian Tube Carcinoma
- +8 more
- Bevacizumab
- Irinotecan Sucrosofate
-
Chicago, IllinoisNorthwestern University
Dec 21, 2022
Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell
Recruiting
- Recurrent Adult T-Cell Leukemia/Lymphoma
- +3 more
- Cyclophosphamide
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 18, 2022
Exposure to Magnetic Field, Hypotension During Dialysis, Disturbance; Balance, Fluid Trial in Aachen (Dermal nuclear magnetic
Terminated
- Exposure to Magnetic Field
- +2 more
- Dermal nuclear magnetic resonance (NMR)-profile measurement
-
Aachen, NRW, GermanyUniversity Hospital of RWTH Aachen, Department of Medicine II
Mar 23, 2021
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,
Recruiting
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Bevacizumab
- +4 more
-
Phoenix, Arizona
- +2 more
Jun 27, 2022
Recurrent DLBCL, Recurrent High Grade B-Cell Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma Trial in United States
Active, not recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +5 more
- Mogamulizumab
- Pembrolizumab
-
Sacramento, California
- +7 more
Sep 15, 2022
Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial
Recruiting
- Resectable Hepatocellular Carcinoma
- +4 more
- Atezolizumab
- +2 more
-
Houston, Texas
- +1 more
Oct 12, 2022
Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo
Not yet recruiting
- Fallopian Tube Carcinosarcoma
- +10 more
- Bevacizumab
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 29, 2022
Moderately to Severely Active Rheumatoid Arthritis Trial in Jiujiang (HLX01, Methotrexate(MTX))
Completed
- Moderately to Severely Active Rheumatoid Arthritis
-
Jiujiang, Jiangxi, ChinaJiujiang No.1 peoples's hospital
May 4, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +5 more
- Bevacizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 1, 2022
Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in
Not yet recruiting
- Ovarian Clear Cell Adenocarcinoma
- +14 more
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140
- +4 more
-
Buffalo, New York
- +1 more
Dec 16, 2022
Pancreatic Adenocarcinoma Non-resectable, Pancreatic Adenocarcinoma Metastatic, Colorectal Cancer Metastatic Trial in New York
Completed
- Pancreatic Adenocarcinoma Non-resectable
- +2 more
- RENCA macrobeads
-
New York, New YorkWeill Cornell Medical Center / The Rogosin Institute
Apr 23, 2021
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +9 more
- Bevacizumab
- Brigatinib
-
Duarte, California
- +4 more
Aug 17, 2022
Advanced Malignant Tumor Trial in Shanghai (Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant
Recruiting
- Advanced Malignant Tumor
- Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection (CDP1)
-
Shanghai, Shanghai, ChinaDragonboat Biopharmaceutical,Co.,Ltd
Feb 3, 2021